FDA Increases Warnings About Risk of Combining Opioids and Benzodiazepines

    The Food and Drug Administration (FDA) has stepped up warnings about the dangers of combing opioid painkillers with benzodiazepine sedatives. The agency is requiring new warnings on labels for opioids such as oxycodone, hydrocodone and morphine, as well as for benzodiazepines such as alprazolam and diazepam.

    Xanax is a commonly used benzodiazepine. A total of 389 drugs are covered by the new warnings, The Wall Street Journal reports.

    “It is nothing short of a public health crisis when you see a substantial increase of avoidable overdose and death related to two widely used drug classes being taken together,” FDA Commissioner Robert Califf, MD, said in a news release.

    By Partnership Staff
    September 2016

    Published

    September 2016

    We use cookies to improve your experience and serve you relevant information. To learn more, read our privacy policy.